|
|
Volumn 33, Issue 3, 2001, Pages 2079-2080
|
|
New immunosuppressives and clinical studies: an embarrassment of riches or more toxicity management? Introduction.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMMUNOSUPPRESSIVE AGENT;
NEUROPROTECTIVE AGENT;
ALLOTRANSPLANTATION;
ANIMAL;
ARTICLE;
BRAIN DISEASE;
CLASSIFICATION;
DIABETES MELLITUS;
ENTERITIS;
HISTOCOMPATIBILITY;
HUMAN;
IMMUNOLOGY;
MULTIPLE SCLEROSIS;
PSORIASIS;
RHEUMATOID ARTHRITIS;
XENOGRAFT;
ANIMALS;
ARTHRITIS, RHEUMATOID;
BRAIN DISEASES;
DIABETES MELLITUS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFLAMMATORY BOWEL DISEASES;
MULTIPLE SCLEROSIS;
NEUROPROTECTIVE AGENTS;
PSORIASIS;
TRANSPLANTATION IMMUNOLOGY;
TRANSPLANTATION, HETEROLOGOUS;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 0035344853
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)01956-X Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
